Today, CMR Surgical Ltd, the British company behind the next-generation surgical robot has been awarded “Venture Financing Deal of the Year” as part of the inaugural Medtech Insight Awards 2018.
Held in partnership with The MedTech Conference in Philadelphia, the Medtech Insight Awards honour and applaud those who, through their passion and unwavering commitment, are driven to cure, inform, minimise treatment burden, and make human lives better.
CMR Surgical was awarded for its record-breaking Series B funding round in June, which raised $100 million, the largest ever series B raise by a medical device company in Europe. The company has recently revealed its next-generation surgical robot Versius, designed to meet the complex requirements of minimal access surgery. Versius resets expectations of robotic surgery by providing a versatile system that is portable, transportable and affordable.
Martin Frost, Chief Executive Officer of CMR Surgical, commented: “We are honoured to accept this prestigious award. Success in this competitive category is testament to our rapid growth and impressive financial backing from existing and new investors. Versius will be a life-changing solution which we expect to change the take up of minimal access surgery worldwide.”
CMR Surgical will use the proceeds from Series B to prepare its Versius® system for planned commercialisation. Activities will include the completion of validation studies for regulatory approval processes in both Europe and the USA, international expansion, and commercial scale-up in response to considerable industry interest in adoption of this new product.